{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:32:11Z","timestamp":1789723931319,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,4,22]],"date-time":"2012-04-22T00:00:00Z","timestamp":1335052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s10072-012-1092-z","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T18:09:32Z","timestamp":1335031772000},"page":"655-661","source":"Crossref","is-referenced-by-count":24,"title":["Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"34","author":[{"given":"Xiao-Ke","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Hua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilhard","family":"Mix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,22]]},"reference":[{"key":"1092_CR1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","volume":"352","author":"AF Hahn","year":"1998","unstructured":"Hahn AF (1998) Guillain-Barr\u00e9 syndrome. Lancet 352:635\u2013641","journal-title":"Lancet"},{"key":"1092_CR2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","volume":"16","author":"S Vucic","year":"2009","unstructured":"Vucic S, Kiernan MC, Cornblath DR (2009) Guillain-Barr\u00e9 syndrome: an update. J Clin Neurosci 16:733\u2013741","journal-title":"J Clin Neurosci"},{"key":"1092_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-009-0097-x","volume":"256","author":"J Brettschneider","year":"2009","unstructured":"Brettschneider J, Petzold A, S\u00fcssmuth S, Tumani H (2009) Cerebrospinal fluid biomarkers in Guillain-Barr\u00e9 syndrome\u2014where do we stand? J Neurol 256:3\u201312","journal-title":"J Neurol"},{"key":"1092_CR4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mus.20022","volume":"29","author":"PY Bergh Van Den","year":"2004","unstructured":"Van Den Bergh PY, Pi\u00e9ret F (2004) Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 29:565\u2013574","journal-title":"Muscle Nerve"},{"key":"1092_CR5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2:750\u2013753","journal-title":"Lancet"},{"issue":"suppl","key":"1092_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ana.410090704","volume":"9","author":"JW Prineas","year":"1981","unstructured":"Prineas JW (1981) Pathology of the Guillain-Barr\u00e9 syndrome. Ann Neurol 9(suppl):6\u201319","journal-title":"Ann Neurol"},{"key":"1092_CR7","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR (2005) Guillain-Barr\u00e9 syndrome. Lancet 366:1653\u20131666","journal-title":"Lancet"},{"key":"1092_CR8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"C Hafer-Macko","year":"1996","unstructured":"Hafer-Macko C, Hsieh ST, Li CY et al (1996) Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40:635\u2013644","journal-title":"Ann Neurol"},{"key":"1092_CR9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA Doorn Van","year":"2008","unstructured":"Van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome. Lancet Neurol 7:939\u2013950","journal-title":"Lancet Neurol"},{"key":"1092_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0404.1994.tb01628.x","volume":"89","author":"K Mokuno","year":"1994","unstructured":"Mokuno K, Kiyosawa K, Sugimura K et al (1994) Prognostic value of cerebrospinal fluid neuron specific enolase and S-100b protein in Guillain-Barr\u00e9 syndrome. Acta Neurol Scand 89:27\u201330","journal-title":"Acta Neurol Scand"},{"key":"1092_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(01)01556-7","volume":"300","author":"SD S\u00fcssmuth","year":"2001","unstructured":"S\u00fcssmuth SD, Reiber H, Tumani H (2001) Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases. Neurosci Lett 300:95\u201398","journal-title":"Neurosci Lett"},{"key":"1092_CR12","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/01.wnl.0000240119.29939.c7","volume":"67","author":"K Jin","year":"2006","unstructured":"Jin K, Takeda A, Shiga Y et al (2006) CSF tau protein: a new prognostic marker for Guillain-Barr\u00e9 syndrome. Neurology 67:1470\u20131472","journal-title":"Neurology"},{"key":"1092_CR13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-1759(03)00189-3","volume":"278","author":"A Petzold","year":"2003","unstructured":"Petzold A, Keir G, Green AJ, Giovannoni G, Thompson EJ (2003) A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods 278:179\u2013190","journal-title":"J Immunol Methods"},{"key":"1092_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2011.01.025","volume":"304","author":"P Singh","year":"2011","unstructured":"Singh P, Yan J, Hull R et al (2011) Levels of phosphorylated axonal neurofilament subunit H (pNFH) are increased in acute ischemic stroke. J Neurol Sci 304:117\u2013121","journal-title":"J Neurol Sci"},{"key":"1092_CR15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10571-007-9257-7","volume":"28","author":"YR Yang","year":"2008","unstructured":"Yang YR, Liu SL, Qin ZY et al (2008) Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barr\u00e9 syndrome. Cell Mol Neurobiol 28:737\u2013744","journal-title":"Cell Mol Neurobiol"},{"key":"1092_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.59.1.84","volume":"59","author":"IS Merkies","year":"2002","unstructured":"Merkies IS, Schmitz P, Van Der Meche FG et al (2002) Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 59:84\u201391","journal-title":"Neurology"},{"key":"1092_CR17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1212\/01.wnl.0000237334.69665.92","volume":"67","author":"A Petzold","year":"2006","unstructured":"Petzold A, Hinds N, Murray NM et al (2006) CSF neurofilament levels: a potential prognostic marker in Guillain-Barr\u00e9 syndrome. Neurology 67:1071\u20131073","journal-title":"Neurology"},{"key":"1092_CR18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mus.21239","volume":"40","author":"A Petzold","year":"2009","unstructured":"Petzold A, Brettschneider J, Jin K et al (2009) CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barr\u00e9 syndrome. Muscle Nerve 40:42\u201349","journal-title":"Muscle Nerve"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-012-1092-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-012-1092-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-012-1092-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:19:43Z","timestamp":1559121583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-012-1092-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,22]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1007\/s10072-012-1092-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,22]]}}}